We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Curious about LyondellBasell (LYB) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Read MoreHide Full Article
The upcoming report from LyondellBasell (LYB - Free Report) is expected to reveal quarterly earnings of $0.87 per share, indicating a decline of 61.2% compared to the year-ago period. Analysts forecast revenues of $7.41 billion, representing a decline of 29.9% year over year.
The consensus EPS estimate for the quarter has been revised 3.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain LyondellBasell metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts expect 'Revenues- Advanced Polymer Solutions' to come in at $926.05 million. The estimate points to a change of -2.3% from the year-ago quarter.
Analysts forecast 'Revenues- Olefins and Polyolefins- Americas' to reach $2.73 billion. The estimate indicates a year-over-year change of -6.7%.
The average prediction of analysts places 'Revenues- Intermediates & Derivatives' at $2.32 billion. The estimate points to a change of -16.9% from the year-ago quarter.
The consensus among analysts is that 'Revenues- Technology' will reach $145.00 million. The estimate indicates a change of -8.8% from the prior-year quarter.
Analysts predict that the 'Revenues- Olefins and Polyolefins- Europe, Asia, International' will reach $2.60 billion. The estimate points to a change of -8.5% from the year-ago quarter.
Analysts' assessment points toward 'EBITDA- Olefins & Polyolefins- Americas' reaching $323.25 million. Compared to the current estimate, the company reported $670.00 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'EBITDA- Olefins & Polyolefins- Europe, Asia, International' will likely reach $45.75 million. The estimate compares to the year-ago value of $70.00 million.
The consensus estimate for 'EBITDA- Advanced Polymer Solutions' stands at $31.88 million. Compared to the current estimate, the company reported $40.00 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'EBITDA- Technology' should arrive at $67.58 million. The estimate compares to the year-ago value of $84.00 million.
It is projected by analysts that the 'EBITDA- Intermediates & Derivatives' will reach $253.36 million. The estimate compares to the year-ago value of $794.00 million.
LyondellBasell shares have witnessed a change of +2.1% in the past month, in contrast to the Zacks S&P 500 composite's +3.4% move. With a Zacks Rank #5 (Strong Sell), LYB is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Curious about LyondellBasell (LYB) Q2 Performance? Explore Wall Street Estimates for Key Metrics
The upcoming report from LyondellBasell (LYB - Free Report) is expected to reveal quarterly earnings of $0.87 per share, indicating a decline of 61.2% compared to the year-ago period. Analysts forecast revenues of $7.41 billion, representing a decline of 29.9% year over year.
The consensus EPS estimate for the quarter has been revised 3.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.
In light of this perspective, let's dive into the average estimates of certain LyondellBasell metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts expect 'Revenues- Advanced Polymer Solutions' to come in at $926.05 million. The estimate points to a change of -2.3% from the year-ago quarter.
Analysts forecast 'Revenues- Olefins and Polyolefins- Americas' to reach $2.73 billion. The estimate indicates a year-over-year change of -6.7%.
The average prediction of analysts places 'Revenues- Intermediates & Derivatives' at $2.32 billion. The estimate points to a change of -16.9% from the year-ago quarter.
The consensus among analysts is that 'Revenues- Technology' will reach $145.00 million. The estimate indicates a change of -8.8% from the prior-year quarter.
Analysts predict that the 'Revenues- Olefins and Polyolefins- Europe, Asia, International' will reach $2.60 billion. The estimate points to a change of -8.5% from the year-ago quarter.
Analysts' assessment points toward 'EBITDA- Olefins & Polyolefins- Americas' reaching $323.25 million. Compared to the current estimate, the company reported $670.00 million in the same quarter of the previous year.
The combined assessment of analysts suggests that 'EBITDA- Olefins & Polyolefins- Europe, Asia, International' will likely reach $45.75 million. The estimate compares to the year-ago value of $70.00 million.
The consensus estimate for 'EBITDA- Advanced Polymer Solutions' stands at $31.88 million. Compared to the current estimate, the company reported $40.00 million in the same quarter of the previous year.
Based on the collective assessment of analysts, 'EBITDA- Technology' should arrive at $67.58 million. The estimate compares to the year-ago value of $84.00 million.
It is projected by analysts that the 'EBITDA- Intermediates & Derivatives' will reach $253.36 million. The estimate compares to the year-ago value of $794.00 million.
View all Key Company Metrics for LyondellBasell here>>>LyondellBasell shares have witnessed a change of +2.1% in the past month, in contrast to the Zacks S&P 500 composite's +3.4% move. With a Zacks Rank #5 (Strong Sell), LYB is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .